CHAPTER 1.2 – Liposome research in drug delivery and targeting: thoughts of an early participant

[1]  G. Gregoriadis,et al.  Interleukin-15 acts as an immunological co-adjuvant for liposomal antigen in vivo. , 1997, Immunology letters.

[2]  G. Gregoriadis,et al.  Liposome‐mediated DNA vaccination , 1997, FEBS letters.

[3]  G. Gregoriadis,et al.  Comparative studies of the fate of free and liposome-entrapped hydroxypropyl-beta-cyclodextrin/drug complexes after intravenous injection into rats: implications in drug delivery. , 1996, Biochimica et biophysica acta.

[4]  M. Palmer.  Liposomes for gene therapy : Receptor ligand-facilitated gene transfer: enhancement of liposome-mediated gene transfer and expression by transferrin Cheng, P-W. (1996) Hum. Gene Ther. 7, 275–282 , 1996 .

[5]  G. Gregoriadis.  Demetrios papahadjopoulos: An encounter of the greek kind , 1995 .

[6]  G. Gregoriadis.  Proceedings Articles: “… Twinkling guide stars to throngs of acolytes desirous of your membranous semi-barriers. Precursors of bion, potential drug carriers …” , 1995 .

[7]  E. Wagner,et al.  Synthesis and anti-HIV activity of thiocholesteryl-coupled phosphodiester antisense oligonucleotides incorporated into immunoliposomes. , 1994, Antiviral research.

[8]  A. Gabizon,et al.  Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[9]  C. Alving,et al.  Liposomes as carriers of antigens and adjuvants. , 1991, Journal of immunological methods.

[10]  G Gregoriadis,et al.  Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. , 1991, Biochimica et biophysica acta.

[11]  G Blume,et al.  Liposomes for the sustained drug release in vivo. , 1990, Biochimica et biophysica acta.

[12]  Kazuo Maruyama,et al.  Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes , 1990, FEBS letters.

[13]  G. Gregoriadis,et al.  Is half‐life of circulating liposomes determined by changes in their permeability? , 1982, FEBS letters.

[14]  G. Gregoriadis,et al.  The phospholipid component of small unilamellar liposomes controls the rate of clearance of entrapped solutes from the circulation , 1980, FEBS letters.

[15]  P. Beaumier,et al.  Hepatic uptake and degradation of unilamellar sphingomyelin/cholesterol liposomes: a kinetic study. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[16]  G. Gregoriadis,et al.  Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. , 1980, The Biochemical journal.

[17]  J. Parks,et al.  Disintegration of phosphatidylcholine liposomes in plasma as a result of interaction with high-density lipoproteins. , 1978, Biochimica et biophysica acta.

[18]  G. Gregoriadis.  The Carrier Potential of Liposomes in Biology and Medicine , 1976 .

[19]  G Gregoriadis,et al.  The carrier potential of liposomes in biology and medicine (second of two parts). , 1976, The New England journal of medicine.

[20]  G. Gregoriadis,et al.  Homing of liposomes to target cells. , 1975, Biochemical Society transactions.

[21]  R L Juliano,et al.  The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs. , 1975, Biochemical and biophysical research communications.

[22]  A. Allison,et al.  Liposomes as immunological adjuvants , 1974, Nature.

[23]  G Gregoriadis,et al.  Entrapment of proteins in liposomes prevents allergic reactions in pre‐immunised mice , 1974, FEBS letters.

[24]  G Gregoriadis,et al.  Drug-carrier potential of liposomes in cancer chemotherapy. , 1974, Lancet.

[25]  G Gregoriadis,et al.  Drug entrapment in liposomes , 1973, FEBS letters.

[26]  G. Gregoriadis,et al.  Enzyme-containing Liposomes alleviate a Model for Storage Disease , 1973, Nature.

[27]  G. Gregoriadis,et al.  Lysosomal localization of -fructofuranosidase-containing liposomes injected into rats. , 1972, The Biochemical journal.

[28]  G. Gregoriadis,et al.  Fate of protein-containing liposomes injected into rats. An approach to the treatment of storage diseases. , 1972, European journal of biochemistry.

[29]  I. Sternlieb,et al.  Catabolism of desialylated ceruloplasmin in the liver. , 1970, The Journal of biological chemistry.

[30]  A. Bangham,et al.  Biophysical properties of phospholipids. II. Permeability of phosphatidylserine liquid crystals to univalent ions. , 1966, Biochimica et biophysica acta.

[31]  A. Bangham,et al.  Diffusion of univalent ions across the lamellae of swollen phospholipids. , 1965, Journal of molecular biology.